4007787550
|
 |
||||||||||||||
| 貨號 | 品名 | 規(guī)格 | 包裝 | 單價 | 貨期 | 庫存 |
| JD200512101806 | 那他珠單抗 | -- | 5mg | 0元 | 咨詢客服 | 3天 |
| JD200512101806 | 那他珠單抗 | -- | 1mg | 0元 | 咨詢客服 | 3天 |
| 性狀： | Natalizumab 是一種重組的人源化單克隆抗體，與 α4β1-整聯(lián)蛋白 (α4β1-integrin) 結(jié)合并阻斷其與血管細胞粘附分子 1 (VCAM-1) 的相互作用。Natalizumab 可用于治療復發(fā)緩解型多發(fā)性硬化癥和克羅恩氏病。Natalizumab 也可阻止淋巴細胞進入中樞神經(jīng)系統(tǒng)，從而防止急性脫髓鞘復發(fā) |
| 質(zhì)量標準： | Description Natalizumab is a recombinant, humanized monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses[1]. |
| 貯存： | SMILES [Natalizumab] Storage Please store the product under the recommended conditions in the Certificate of Analysis. References |
